title: Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.
abstract: Flibanserin (Addyi) for female sexual interest/arousal disorder in premenopausal women.
authors.forename: Clayton
authors.initials: C
authors.lastname: English
authors.forename: Anne
authors.initials: A
authors.lastname: Muhleisen
authors.forename: Jose A
authors.initials: JA
authors.lastname: Rey